|
|||||
|
|
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program,United States, December 2022–January 2023 |
|
| Authors: | Ruth Link-Gelles Allison Avrich Ciesla Lauren E. Roper Heather M. Scobie Akilah R. Ali Joseph D. Miller Ryan E. Wiegand Emma K. Accorsi Jennifer R. Verani Nong Shang Gordana Derado Amadea Britton Zachary R. Smith Katherine E. Fleming-Dutra |
| Affiliation: | 1.National Center for Immunization and Respiratory Diseases, CDC; 2.Eagle Health Analytics, San Antonio, Texas; 3.Center for Preparedness and Response, CDC. 4.Epidemic Intelligence Service, CDC. |
| Abstract: | |
| Keywords: | |